Dr. Wael Barsoum Accepts New Role with Healthcare Outcomes Performance Company

Now to Become HOPCo’s President and Chief Transformation Officer

Phoenix, AZ (June 25, 2020) – Healthcare Outcomes Performance Company (HOPCo), the national leader in musculoskeletal value-based health outcomes management, service line management and practice management, has announced that Dr. Wael Barsoum has been appointed to the role of President and Chief Transformation Officer.  For the past six years, Dr. Barsoum served as the CEO and President of Cleveland Clinic Florida and was responsible for significant growth in both size and revenue.  Last year, HOPCo expanded into the Florida market through a partnership with Jacksonville based Southeast Orthopedic Specialists.  Dr. Barsoum will remain in Ft. Lauderdale to help lead HOPCo’s expansion both in Florida and on a national level beginning on August 15, 2020.

“The addition of Dr. Barsoum is a major milestone for us,” said Founder and CEO of HOPCo, Dr. David Jacofsky.  “Our executive team is comprised of some of the most forward-thinking minds in healthcare and Dr. Barsoum’s history of innovation and commitment to value-based care makes him the ideal leader to assume this role”.

In his role as President and Chief Transformation Officer, Dr. Barsoum will lead HOPCo’s market transformation initiatives by further aligning stakeholders to continue the shift from volume-based care to value-based care models.  He will also oversee HOPCo’s musculoskeletal service line hospital integrations, musculoskeletal specialty hospitals, quality programs as well as operations.

“HOPCo has emerged as a strong leader in the musculoskeletal space,” said Dr. Barsoum. “I am truly excited about the opportunity to help drive the national expansion of their proven value-based care and population health models”.

During his tenure as CEO and President of Cleveland Clinic Florida, Dr. Barsoum cultivated and transformed Cleveland Clinic Florida from a $600M, single, 155-bed hospital system with 9 remote sites to a $1.8B, 5-hospital, 1,083-bed tertiary and quaternary care hospital system with over 40 regional sites.  Dr. Barsoum is an effective visionary adept at forecasting future challenges and instituting roadmaps for organizational success, while simultaneously being an active joint replacement surgeon and the Co-Editor in Chief of The Journal of Hip Surgery. He has published over 200 peer-reviewed articles, presented at over 300 conferences internationally and is a member of the prestigious Hip Society as well as the Knee Society. Dr. Barsoum also currently holds the Robert and Suzanne Tomsich Distinguished Chair in Healthcare Innovation and has been the principal investigator for clinical, basic science and translational studies with over 50 granted or pending US patents.